Citations

Institution: Mayo Clinic Clear

Showing 10 of 108104 citations.

Predictors of treatment response and overall survival in patients with breast cancer brain metastases treated with stereotactic radiosurgery: a prospective study using the NeuroPoint Alliance SRS Registry
D’Ambrosio, Anthony, Cobb, William S., Grills, Inga S., McInerney, James , Jensen, Randy L. , Chang, Eric L. , Timmerman, Robert , Attia, Albert, Spalding, Aaron C., Walter, Kevin A. , Bydon, Mohamad , Asher, Anthony L. , Sheehan, Jason P. , Katsos, Konstantinos, Katsos, Konstantinos, Michalopoulos, Giorgos D. , Cobb, William S., Andrews, David William , Pouratian, Nader

Journal of Neurosurgery | June 27, 2025 | Volume: 143 | Issue: 5 | Pages: 1419-1430

10.3171/2025.3.jns241471 | PMID 40577855 Get It

OBJECTIVE The aim of this study was to evaluate mortality and progression outcomes in patients undergoing stereotactic radiosurgery (SRS) for breast cancer brain metastases and to identify associated risk factors using a national quality registry. METHODS The NeuroPoint Alliance (NPA) SRS Registry was employed for this study, which conducted prospective enrollment of patients undergoing SRS at 16 participating centers from 2017 to 2024. Outcomes of interest included the post-SRS EQ-5D score change, overall survival, local progression, out-of-field progression, and overall intracranial progression. For all time-to-event analyses, Kaplan-Meier curves and multivariable Cox regressions with hazard ratios were used. RESULTS A total of 138 patients (127 female, mean age 59.8 years) were identified; 46.4% had a single lesion, 42.0% had 2–4 lesions, and 11.6% had ≥ 5 lesions, while 87.0% had a Karnofsky Performance Status (KPS) score between 80 and 100. The median overall survival was 17.9 months, and independent predictors of all-cause mortality included a KPS score ≤ 90 (HR 6.73) and diabetes mellitus (HR 3.35). The median time to local progression was 19.8 months. More than 5 lesions at baseline (HR 9.03) and a marginal dose ≤ 17.6 Gy (HR 8.00) were predictive of local recurrence. The median was not reached for out-of-field progression, and predictors included ≥ 2 lesions at the time of SRS (HR 3.20) and a marginal dose ≤ 17.6 Gy (HR 4.61). At the final follow-up assessment, 17.1% of patients experienced no change according to the EQ-5D, while 34.3% had improvement, 11.4% had mixed results, and 37.1% had worsened health. In the multivariable linear regression model, pre-SRS resection (r = 1.92) and baseline EQ-5D score (r = 1.29) were statistically significant predictors of quality of life at the final follow-up assessment. CONCLUSIONS Using real-world data from the NPA SRS Registry, this study demonstrated comparable outcomes in patients who underwent SRS for breast cancer brain metastases compared with those of previous literature. The number of lesions at the time of SRS and the marginal dose were independent risk factors for local recurrence, out-of-field progression, and overall intracranial progression. Pre-SRS resection and baseline EQ-5D score were independent predictors of quality of life following SRS.
Evaluating longitudinal changes of gait parameters following shunt placement in patients with idiopathic normal pressure hydrocephalus
Pennington, Zach , Potes, Maria Astudillo , Hallak, Hana , Rezaei, Asghar , Jusué-Torres, Ignacio , Graff-Radford, Jonathan, Cutsforth‐Gregory, Jeremy K. , Ali, Farwa, Elder, Benjamin D. , Pennington, Zach , Jusue-Torres, Ignacio , Kumar, Rahul , Hamouda, Abdelrahman M. , Shafi, Mahnoor , Bhat, Sandesh G. , Graff‐Radford, Jonathan , Jones, David , Botha, Hugo , Ali, Farwa , Cogswell, Petrice M. , Kaufman, Kenton R.

Journal of Neurosurgery | June 27, 2025 | Volume: 143 | Issue: 5 | Pages: 1254-1261

10.3171/2025.3.jns241416 | PMID 40513237 Get It

OBJECTIVE Idiopathic normal pressure hydrocephalus (iNPH) is characterized by gait deterioration, cognitive disturbances, and urinary incontinence. Gait deficits pose safety hazards due to frequent falls, yet objective investigations of gait improvement following ventriculoperitoneal shunt (VPS) placement are limited. Therefore, the aim of this study was to assess objective improvement in gait parameters for patients with iNPH after VPS placement. METHODS All patients treated with a VPS for iNPH by the senior author at a single tertiary care center from December 2017 to January 2023 were retrospectively reviewed. Patients who underwent detailed motion analysis testing before surgery with > 1 follow-up assessment were included. Analyzed parameters included gait velocity, gait cadence, stride length, stride width, gait stability ratio, total support, and single support. Time-dependent linear mixed-effects models and generalized additive mixed-effects models (GAMMs) were used to model short-term and longitudinal gait parameter changes, respectively. RESULTS A total of 212 patients (137 male, median age was 75.2 years) who underwent VPS placement for iNPH were included, with a total of 747 gait analyses performed at a median last-gait analysis follow-up duration of 12.0 months. Statistically significant changes in all gait parameter values were seen between the preoperative time point and first postoperative follow-up (within 3 months) time point (paired Wilcoxon p < 0.001), with a statistically significant majority of patients experiencing improvement (binominal p < 0.0001). Longitudinal analyses using a GAMM showed increased gait velocity, single support, and stride length, with decreased stability ratio, step width, and total support at early time points, while a plateau was achieved around 6 months. CONCLUSIONS A detailed gait analysis demonstrated significant improvements in objective ambulation metrics, particularly in the gait velocity, stride length, and gait stability ratio, following VPS placement in patients with iNPH. Most patients maintained marked improvement from baseline to the last follow-up assessment, although a plateau of the benefit was experienced over longer follow-up.
A 72‐Year‐Old Man With a History of Rheumatoid Arthritis Presenting With Unilateral Eye and Jaw Pain
Hassoun, Mohamad Rani , Cherayil, Neena R. , Cherayil, Neena R.

Annals of Clinical and Translational Neurology | June 27, 2025 | Volume: 12 | Issue: 9 | Pages: 1942-1943

10.1002/acn3.70030 | PMID 40579385 Get It

Survey of Early Practices and Perceptions of Liver Machine Perfusion Among US Liver Transplant Surgeons
Nguyen, Michelle , Li, Xingjie , Ohara, Stephanie, Motamed, Mehrdad, Moss, Adyr A. , Reddy, Kunam S. , Mathur, Amit K. , Nguyen, Michelle C , Zhang, Chi , Motamed, Mehrdad, Jadlowiec, Caroline C.

Transplantation Direct | June 27, 2025 | Volume: 11 | Issue: 7 | Pages: e1841

10.1097/txd.0000000000001841 | PMID 40590003 Get It

Background. Ex vivo machine perfusion (MP) has transformed organ preservation, offering significant benefits in liver transplantation (LT), particularly with high-risk donor grafts. However, adoption in the United States has been limited. We aimed to examine early adoption trends, surgeon perceptions, and barriers to implementing MP in the United States after Food and Drug Administration approval of MP platforms. Methods. A 23-question electronic survey was distributed to members of the American Society of Transplant Surgeons between October and November 2022, capturing attitudes and practices related to MP adoption. Responses from 96 surgeons representing 77 LT centers across 11 Organ Procurement and Transplantation Network regions were analyzed. Results. Forty-four respondents (48%) reported having an MP program at their institution. Adoption of MP was significantly more common in high-volume centers and those performing ≥20 donation after circulatory death (DCD) transplants annually (P < 0.001). MP utilization received strong support, with 88% endorsing its use for DCD liver allografts and 82% for donation after brain death allografts. Respondents cited MP’s ability to reduce ischemic cholangiopathy, enable graft repair, and facilitate viability assessment as key benefits. Normothermic MP was preferred for high-risk donor profiles, including DCD grafts, older donors, and steatotic livers, and was associated with an increased willingness to accept medically complex grafts compared with static cold storage. Barriers to MP utilization included program costs, personnel demands, and logistical complexities. Centers with higher proportions of privately insured patients were more likely to adopt MP. Despite these challenges, 84% of respondents expressed interest in future MP adoption. Conclusions. MP enhances graft utilization and outcomes, particularly for complex and high-risk donor livers, but widespread US adoption requires addressing financial and logistical barriers. Future efforts should focus on refining cost-effectiveness analyses, collaboration with organ procurement organizations and device companies, and developing standardized training to optimize MP integration and maximize its clinical impact on LT.
Open-Source Hybrid Large Language Model Integrated System for Extraction of Breast Cancer Treatment Pathway From Free-Text Clinical Notes
Tariq, Amara , Sikha, Madhu Babu , Kurian, Allison W. , Ward, Kevin C. , Keegan, Theresa H.M. , Rubin, Daniel L. , Banerjee, Imon , Sikha, Madhu , Ward, Kevin , Banerjee, Imon , Kurian, Allison W , Rubin, Daniel L

JCO Clinical Cancer Informatics | June 27, 2025 | Volume: No volume available | Issue: 9 | Pages: No page available

10.1200/cci-25-00002 | PMID 40577660 Get It

PURPOSE Automated curation of breast cancer treatment data with minimal human involvement could accelerate the collection of statewide and nationwide evidence for patient management and assessing the effectiveness of treatment pathways. The primary challenges are the complexity and inconsistency of structured clinical data streams and accurate extraction of this information from free-text clinical narratives. MATERIALS AND METHODS We proposed a hybrid two-phase information extraction framework that combined a Unified Medical Language System parser (phase-1) with a fine-tuned large language model (LLM; phase-2) to extract longitudinal treatment timelines from time-stamped clinical notes. Our framework was developed through end-to-end joint learning as a question-answering model, where the model was trained to simultaneously answer five questions, each corresponding to a specific treatment. RESULTS We fine-tuned and internally validated the model on 26,692 patients with breast cancer (diagnosed between 2013 and 2020) receiving treatment at Mayo Clinic and externally validated the model on 162 randomly selected patients from Stanford Healthcare. Zero-shot LLM (out-of-the-box) had high specificity but low sensitivity, indicating that although these frameworks are useful for generic language understanding, they are lacking in terms of targeted clinical tasks. The proposed model achieved 0.942 average AUROC on the internal and 0.924 on the external data, demonstrating only marginal drop in performance when evaluated on external. The proposed model also achieved better trade-off between sensitivity (average: 79.2%) and specificity (average: 76.2%) compared with rule-based (average sensitivity: 70.5%, average specificity: 68.1%) and structured codes (average sensitivity: 64.1%, average specificity: 83.5%). CONCLUSION The proposed framework can extract temporal information about cancer treatments from various time-stamped clinic notes, regardless of the setting of treatment administration (inpatient or outpatient) or time frame. To support the cancer research community for such data curation and longitudinal analysis, we have packaged the code as a docker image, which needs minimal system reconfiguration and shared with an open-source academic license.
The Influence of the Coronavirus Disease 2019 Pandemic on Influenza Vaccination Refusal and Patient Satisfaction
Man, Olivia , McHugh, Jack , Wilshusen, Laurie , Hart, Lacey, Welch, Tripp, O’Horo, John C. , Man, Olivia M , McHugh, Jack , Wilshusen, Laurie L , O'Horo, John C , Challener, Douglas , Young, Jeremy, Welch, Tripp, Challener, Douglas W.

Open Forum Infectious Diseases | June 27, 2025 | Volume: 12 | Issue: 7 | Pages: No page available

10.1093/ofid/ofaf351 | PMID 40630935 Get It

Abstract Background We examined how the COVID-19 pandemic influenced influenza vaccination, healthcare engagement, and patient satisfaction. Methods We retrospectively analyzed influenza vaccination records and patient experience surveys of adult primary care patients in southeastern Minnesota during two 3-year phases: Prepandemic (1 January 2017–28 February 2020) and Pandemic-Plus (1 March 2020–31 December 2023). Vaccination status was defined as “always vaccinated” (AV), “never vaccinated” (NV), or “intermittently vaccinated” (IV) for seasonal influenza. Results During the Pandemic-Plus phase, 7.0% (n = 3556) of the Prepandemic AV and 48.7% (n = 16 710) of the Prepandemic IV patients never received another influenza vaccine. Compared to AV, IV and NV patients were more likely to reside in areas with greater socioeconomic deprivation (odds ratio [OR], 1.58 [95% confidence interval {CI}, 1.53–1.62] and 1.99 [1.94–2.05], respectively), have a high school education or less (2.86 [2.74–2.98] and 3.38 [3.23–3.53]), and report healthcare disengagement (1.59 [1.55–1.64] and 4.21 [4.09–4.33]). After adjusting for Area Deprivation Index and medical comorbidities, healthcare disengagement increased among the NV versus AV between phases (3.33 [3.24–3.41] and 4.23 [4.10–4.35]). In a subgroup analysis those with severe comorbidities were less likely AV (NV vs AV: 1.21 [1.14–1.27]) and more dissatisfied with care (NV vs AV: 1.25 [1.18–1.33]). Conclusions The COVID-19 pandemic altered vaccination behaviors and healthcare satisfaction, especially among those at high risk of developing influenza-related complications. Medical providers and public health officials should be aware of factors associated with vaccine refusal to better target interventions.
Advance at a glance: contributions to cardio-oncology
Herrmann, Joerg

European Heart Journal Open | June 27, 2025 | Volume: 5 | Issue: 3 | Pages: No page available

10.1093/ehjopen/oeaf075 | PMID 40584582 Get It

International Medical Graduates Representation at International Oncology Conference Meetings: An Analysis of ASCO Annual Meetings
Roy, Arya Mariam , Bakouny, Ziad , Dizman, Nazlı , Morgan, Paul , Özay, Zeynep İrem , Lal, Bhavesh Mohan , Nawfal, Rashad , Eid, Marc , Machaalani, Marc , Lopes, Gilberto , Marshall, Ariela L. , Murphy, Martina, Lee, Alfred Ian , Machaalani, Marc , Butt, Ayesha , Aggarwal, Charu , Bekaii-Saab, Tanios S , Chavez-MacGregor, Mariana , Lopes, Gilberto , Marshall, Ariela , Owonikoko, Taofeek Kunle , Xie, Wanling , Lee, Alfred I , Choueiri, Toni K , Bakouny, Ziad , Eid, Marc , Paul, Morgan A., Chehade, Razane El Hajj , Butt, Ayesha , Aggarwal, Charu , Bekaii‐Saab, Tanios , Chávez‐MacGregor, Mariana , Xie, Wanling , Choueiri, Toni K.

JCO Oncology Practice | June 27, 2025 | Volume: 22 | Issue: 4 | Pages: 708-716

10.1200/op-25-00067 | PMID 40577682 Get It

PURPOSE Despite international medical graduates (IMGs) accounting for up to one third of all practicing oncologists in the United States, and nearly half of fellowship trainees, little is known about their contributions to presentations at international oncology meetings. Therefore, we investigated the representation of IMGs in invited faculty roles at the ASCO Annual Meeting as a representative example. METHODS Presentation data from ASCO 2022 and 2023 Annual Meetings were obtained from program guides. We collected presentation-level and speaker-level variables of invited faculty roles and original research. Speakers were categorized as American medical graduate (AMG), IMG, non–US-based, or non-MD (Doctor of Medicine). Univariable and multivariable analyses assessed factors influencing selection for invited faculty roles. RESULTS A total of 2,590 presentations by 2,109 unique speakers were reviewed, including primary research presenters and invited faculty. Among the 1,352 presentations by AMGs, 30% were primary research and 70% were invited faculty roles. For the 374 presentations by IMGs, 41% were primary research and 59% were invited faculty roles. Notably, first-author IMGs were significantly less likely to receive invited faculty roles relative to their primary research output compared with first-author AMGs (adjusted odds ratio, 0.69 [95% CI, 0.53 to 0.90]; P = .006), even when accounting for academic rank, presumed sex, and year. CONCLUSION Relative to IMGs' original research output, IMGs appear to receive fewer invitations for ASCO Annual Meeting invited faculty roles compared with AMGs. Our findings suggest potential underrepresentation and under-recognition of IMGs in these roles, despite their contributions to the oncology workforce in the United States.
TDP-43 pathology induces CD8 + T cell activation through cryptic epitope recognition
Chizari, Shahab , Kong, Steven Lingyang, Saigal, Vidur J., Turchetti, Valentina, Chen, Bingxian, Devine, Connor C., Zampedri, Luca, Skorupinska, Iwona, Minicuci, Giacomo Maria, Paron, Francesca, Tonin, Paola , Marchetto, Giulia, Li, Ziyi , Colón-Mercado, Jennifer M., Barattucci, Simone, Soltic, Darija, Dattilo, Dario, Gatt, Ariana, Hembrador, Jada M., Capasso, Guido, Frezzato, Federica, Trentin, Livio, Lin, Elisabeth, Lopes, Raquel, Routledge, Nathan, Qi, Yue A., Hanna, Michael G., Ward, Michael, Petrucelli, Leonard , Buratti, Emanuele , Machado, Pedro , Fratta, Pietro, Jiang, Ning , Hanna, Michael G. , Ward, Michael E. , Fratta, Pietro , Fratta, Pietro , Kong, Steven , Ward, Michael E , Romano, Maurizio , Machado, Pedro M , Fratta, Pietro , Fratta, Pietro , Zanovello, Matteo , Brown, Anna‐Leigh , Chen, Bingxian, Devine, Connor C., Zampedri, Luca, Skorupinska, Iwona, Minicuci, Giacomo Maria, Paron, Francesca, Marchetto, Giulia, Li, Ziyi, Colón-Mercado, Jennifer M., Barattucci, Simone, Soltic, Darija, Dattilo, Dario, Gatt, Ariana P. , Hembrador, Jada M., Capasso, Guido, Frezzato, Federica, Trentin, Livio, Lin, Elisabeth, Lopes, Raquel, Routledge, Nathan, Qi, Yue A., Hanna, Michael G., Ward, Michael, Vattemi, Gaetano Nicola Alfio , Malaspina, Andrea , Merve, Ashirwad , Sorarú, Gianni , Jiang, Ning

No container title available | June 27, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1101/2025.06.22.660773 | PMID 40667053 Get It

Abstract Aggregation and nuclear depletion of the RNA binding protein TDP-43 are the crucial pathological features of amyotrophic lateral sclerosis (ALS) and inclusion body myositis (IBM), two degenerative diseases of the CNS and muscle. The loss of TDP-43 nuclear function results in the aberrant inclusion of cryptic exons in mRNA transcripts, leading to the expression of de novo proteins. Clonally expanded and highly differentiated CD8 + T cells have been observed in individuals with TDP-43 proteinopathies and therapeutics modulating the T cell response have recently been found to extend survival. However, the target antigens mediating T cell activation have remained elusive. Here, we investigate whether the de novo proteins induced by aberrant cryptic splicing due to TDP-43 nuclear loss can act as neo-antigens. We detect the HDGFL2 cryptic peptide and multiple other TDP-43 cryptic exons in IBM skeletal muscle, where their presence correlates with enrichment of T cells and class I antigen presentation pathways. Furthermore, we identify epitopes deriving from HDGFL2 and IGLON5 cryptic peptides which are recognized by clonally expanded and functionally differentiated populations of CD8 + T cells in ALS and IBM Patients. Finally, we demonstrate that T cells engineered to express the identified TCRs can bind and activate in response to the cryptic peptide derived epitopes (cryptic epitopes) and are able to kill TDP-43 deficient astrocytes. This work identifies for the first time specific T cell antigens in ALS and IBM, directly linking adaptive immune response to TDP-43 pathology.